CRISPR Therapeutics AG (CRSP)
46.29
-0.97
(-2.05%)
USD |
NASDAQ |
Nov 21, 16:00
46.40
+0.11
(+0.24%)
After-Hours: 07:52
CRISPR Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 44.67% |
| September 30, 2023 | |
| June 30, 2023 | -111.1% |
| March 31, 2023 | -53.06% |
| December 31, 2022 | -1.84M% |
| September 30, 2022 | -185.7K% |
| June 30, 2022 | -117.6K% |
| March 31, 2022 | -100.7K% |
| December 31, 2021 | -1.14K% |
| September 30, 2021 | -38.65K% |
| June 30, 2021 | 84.34% |
| March 31, 2021 | -56.02K% |
| December 31, 2020 | -55.17K% |
| September 30, 2020 | -62.46K% |
| June 30, 2020 | -181.0K% |
| March 31, 2020 | -44.41K% |
| December 31, 2019 | 39.66% |
| Date | Value |
|---|---|
| September 30, 2019 | 65.32% |
| June 30, 2019 | -16.89K% |
| March 31, 2019 | -14.76K% |
| December 31, 2018 | -41.38K% |
| September 30, 2018 | -9.01K% |
| June 30, 2018 | -3.53K% |
| March 31, 2018 | -2.08K% |
| December 31, 2017 | 0.44% |
| September 30, 2017 | -1.04K% |
| June 30, 2017 | -623.0% |
| March 31, 2017 | -794.5% |
| December 31, 2016 | |
| September 30, 2016 | -948.6% |
| June 30, 2016 | -2.16K% |
| March 31, 2016 | -1.77K% |
| December 31, 2015 | -4.97K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.84M%
Minimum
Dec 2022
84.34%
Maximum
Jun 2021
-167.9K%
Average
-49.79K%
Median
Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 37.71% |
| AC Immune SA | 21.59% |
| Addex Therapeutics Ltd | -- |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | -2.41K% |